A Randomized Placebo-Controlled Trial of Leronlimab in Mild-To-Moderate COVID-19.
Seethamraju H, Yang OO, Loftus R, Ogbuagu O, Sammartino D, Mansour A, Sacha JB, Ojha S, Hansen SG, Arman AC, Lalezari JP.
Seethamraju H, et al. Among authors: yang oo.
Clin Ther. 2024 Nov;46(11):891-899. doi: 10.1016/j.clinthera.2024.08.019. Epub 2024 Sep 30.
Clin Ther. 2024.
PMID: 39353749
Clinical Trial.